lyophilization comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-09-22. Numbers and descriptions here follow the published literature rather than marketing material.
Identity and purity are established with reversed-phase high-performance liquid chromatography, often paired with mass spectrometry for confirmation of the expected mass. Peptide mapping after enzymatic digestion verifies the primary sequence and detects substitutions. Size-exclusion chromatography quantifies aggregates and fragments, which are the impurities most often tracked for peptides of this size. Residual solvents, counterions, and water content fall under separate tests described in pharmacopeial chapters. Circular dichroism or nuclear magnetic resonance may be used in research settings to probe secondary structure, though such methods are less common in routine release testing.
Peptide active ingredients of this type are typically supplied as lyophilized powder because the dry form resists hydrolysis during transport. The material is hygroscopic, so vials are usually equilibrated to room temperature before opening to avoid condensation on the solid. Repeated freeze-thaw cycles can promote aggregation and are generally avoided by aliquoting stock into single-use portions. Personnel handling the powder work in controlled environments to limit inhalation of fine particles. Written procedures usually specify these steps rather than leaving them to individual judgment.
Clinical development proceeded through large phase 3 programmes in type 2 diabetes and in obesity or overweight with at least one weight-related comorbidity. Regulatory approvals followed in several jurisdictions for both indications. Weekly subcutaneous dosing reflects an elimination half-life of roughly five days. Open questions include the durability of metabolic effects after treatment stops, long-term cardiovascular and hepatic outcomes beyond completed trials, and whether the dual mechanism confers benefits independent of total receptor occupancy. Published literature continues to expand on these points. Substantial uncertainty remains about interindividual variability in response.
Tirzepatide is a synthetic linear peptide of 39 amino acids that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its sequence derives from native GIP but incorporates non-natural residues and a C20 fatty diacid moiety linked to a lysine side chain. The lipophilic chain promotes albumin binding, which slows renal clearance and extends circulation time. The unmodified peptide has a molecular formula of C225H348N48O68 and a molecular mass near 4,813 daltons.
| Property | Value | Notes |
|---|---|---|
| Typical supplied form | Lyophilized powder | Hygroscopic, seal promptly after opening |
| Long-term storage temperature | At or below minus 20 C | Protect from repeated freeze-thaw |
| Working solution stability | Hours when refrigerated | Use within the same working day |
| Primary purity method | Reversed-phase HPLC | Often paired with mass spectrometry |
| Aggregate measurement | Size-exclusion chromatography | Reports high-molecular-weight species |
Identity and purity are assessed by reversed-phase high-performance liquid chromatography, with mass confirmation by electrospray ionisation mass spectrometry. Peptide mapping after enzymatic digestion verifies the primary sequence. Size-exclusion chromatography quantifies aggregates, while circular dichroism provides a secondary-structure fingerprint. Bioanalytical quantification in plasma uses immunoassay or LC-MS/MS. Reported purity for research-grade lots is commonly 95 percent or higher, and residual water content is checked by Karl Fischer titration.
As a peptide, tirzepatide is handled as a lyophilised solid in research settings and as a preserved solution in finished products. Aqueous solubility is pH dependent and reaches a minimum near the isoelectric point, which lies close to pH 5.4. Stock solutions are typically prepared in neutral or slightly basic buffer to limit precipitation. The solid is hygroscopic and should be equilibrated to room temperature before opening so that condensation does not form on the powder surface.
Recommended storage for reference material is a freezer at approximately -20 degrees Celsius, protected from light and moisture. Commercial injectable presentations are stored refrigerated between 2 and 8 degrees Celsius and must not be frozen. Product labelling generally permits a limited period at controlled room temperature once dispensed, with the exact window depending on the presentation. Repeated temperature cycling is avoided because it can promote aggregation or deamidation of the peptide chain.
At the receptor level, the compound binds both GIP and GLP-1 receptors and triggers downstream signalling that raises cyclic AMP in target cells. GLP-1 receptor activation is associated with glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. GIP receptor activation contributes effects that are less completely characterised, and how much each receptor adds to the overall clinical response is still an open question. The two pathways appear to interact in a complementary rather than a purely additive way.
An extended fatty diacid moiety promotes binding to serum albumin, which slows renal clearance and extends the circulating half-life to roughly five days. That property supports once-weekly administration and largely explains the dosing interval described in clinical reports. Published data come mainly from large randomised programmes that evaluated glycaemic control and body weight over periods of many months. Long-term outcomes beyond those trial windows, including what happens after treatment stops, remain an active area of investigation.
Tirzepatide is a synthetic peptide built from thirty-nine amino acids. Its sequence is derived from native glucose-dependent insulinotropic polypeptide, or GIP, with several non-natural residues and a fatty diacid side chain attached through a linker. The molecule behaves as a dual agonist at two incretin receptors, GIP and GLP-1, instead of targeting a single receptor. This dual engagement separates it from earlier single-receptor incretin compounds and underpins most of its reported pharmacological activity.
Bulk peptide material is normally characterised by reversed-phase high-performance liquid chromatography, which separates the target sequence from truncation products and other closely related impurities. Ultraviolet detection near 214 nanometres is common because the peptide backbone absorbs in that region. Mass spectrometry, usually electrospray ionisation coupled to a mass analyser, is used to confirm the molecular mass. Because the molecule carries a lipophilic side chain, gradient methods often need a relatively high organic modifier fraction to elute it within a practical retention window.
Like most synthetic peptides of this size, the material is commonly supplied as a lyophilised powder that appears white to off-white. It dissolves in aqueous buffers and in mixtures of water with a small proportion of organic solvent, though the fatty acid portion reduces solubility in pure water relative to short peptides. Hygroscopic behaviour is reported for many peptide powders, so weighing is usually performed quickly and under controlled humidity. Working solutions are typically prepared fresh and kept cold.
Tirzepatide is a synthetic peptide that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. The molecule contains 39 amino acids and features a C20 fatty diacid moiety attached via a linker, which promotes albumin binding and extends its circulating half-life. Its sequence incorporates non-natural amino acids and modifications that reduce susceptibility to degradation by dipeptidyl peptidase-4. This dual receptor activity distinguishes it from selective GLP-1 receptor agonists.
The GIP receptor is expressed in pancreatic islets, adipose tissue, and the central nervous system, while GLP-1 receptors are found in pancreatic islets, the gastrointestinal tract, and the brain. Activation of both receptors can enhance glucose-dependent insulin secretion and reduce glucagon release. The relative contribution of each receptor to the overall pharmacological effect remains an area of ongoing investigation. Preclinical studies suggest that GIP receptor agonism may modulate appetite and energy balance, but the precise mechanisms in humans are not fully established.
In clinical research, tirzepatide has been studied in randomized controlled trials for glycemic control and body weight reduction. These trials typically measure changes in hemoglobin A1c and body weight over periods of several months. The drug is administered by subcutaneous injection, and its pharmacokinetic profile supports once-weekly dosing. Post-marketing surveillance continues to evaluate long-term outcomes and rare adverse events.
Participatory documentaries believe that it is impossible for the act of filmmaking to not influence or alter the events being filmed. What these films do is emulate the approach of the anthropologist: participant-observation. Not only is the filmmaker part of the film, but we also get a sense of how situations in the film are affected or altered by their presence. Nichols: "The filmmaker steps out from behind the cloak of voice-over commentary, steps away from poetic meditation, steps down from a fly-on-the-wall perch, and becomes a social actor (almost) like any other. (Almost like any other because the filmmaker retains the camera, and with it, a certain degree of potential power and control over events.)" The encounter between filmmaker and subject becomes a critical element of the film. Rouch and Morin named the approach cinéma vérité, translating Dziga Vertov's kinopravda into French; the "truth" refers to the truth of the encounter rather than some absolute truth. Reflexive documentaries do not see themselves as a transparent window on the world; instead, they draw attention to their own constructedness and the fact that they are representations. How does the world get represented by documentary films? This question is central to this subgenre. They prompt us to "question the authenticity of documentary in general." It is the most self-conscious of all the modes, and is highly skeptical of "realism". It may use Brechtian alienation strategies to jar us, in order to "defamiliarize" what we are seeing and how we are seeing it.
It must be made apparent to the Soviet Government that our strength will be sufficient to repel any attack and sufficient to defeat the USSR decisively if a war should start. The prospect of defeat is the only sure means of deterring the Soviet Union. In the early Cold War, US Secretary of State Dean Acheson combined the concepts of preponderance and bandwagoning. As he put it, the United States was going to have to be "the locomotive at the head of mankind," while the rest of the world was going to be "the caboose." While arguing that equilibrium was essential to justice, Reinhold Niebuhr asserted that "nothing but the preponderance of power in the non-Communist world can preserve the peace." Melvyn Leffler describes the US strategy throughout the Cold War as a strategy of preponderance. In its last year, he summarized: Backed by strategic preponderance, the United States integrated and rearmed the Eurasian industrial areas, shored up the Eurasian periphery and rolled back the Iron Curtain. Already during the Cold War, some scholars stressed that the pattern accords the preponderance of power rather than balance of power. The balance of power presupposes such a distribution of power in the system that no single state is preponderant. In this sense, during the period 1945–1965 if "there was any threat to the general balance of power [...] it was from the United States rather than from the Soviet Union that this came." Stephen Walt observed in the 1980s that most states, including all developed states, ally with, rather than balance against, the preponderant power.
=== In vivo === Since the discovery that the direct administration of in vitro transcribed mRNA leads to the expression of antigens in the body, in vivo approaches have been investigated. They offer some advantages over ex vivo methods, particularly by avoiding the cost of harvesting and adapting dendritic cells from patients and by imitating a regular infection. Different routes of injection, such as into the skin, blood, or muscles, result in varying levels of mRNA uptake, making the choice of administration route a critical aspect of in vivo delivery. One study showed, in comparing different routes, that lymph node injection leads to the largest T-cell response.
==== Base-specific cleavage/MALDI-TOF ==== A recently described method by Ehrich et al. further takes advantage of bisulfite-conversions by adding a base-specific cleavage step to enhance the information gained from the nucleotide changes. By first using in vitro transcription of the region of interest into RNA (by adding an RNA polymerase promoter site to the PCR primer in the initial amplification), RNase A can be used to cleave the RNA transcript at base-specific sites. As RNase A cleaves RNA specifically at cytosine and uracil ribonucleotides, base-specificity is achieved by adding incorporating cleavage-resistant dTTP when cytosine-specific (C-specific) cleavage is desired, and incorporating dCTP when uracil-specific (U-specific) cleavage is desired. The cleaved fragments can then be analyzed by MALDI-TOF. Bisulfite treatment results in either introduction/removal of cleavage sites by C-to-U conversions or shift in fragment mass by G-to-A conversions in the amplified reverse strand. C-specific cleavage will cut specifically at all methylated CpG sites. By analyzing the sizes of the resulting fragments, it is possible to determine the specific pattern of DNA methylation of CpG sites within the region, rather than determining the extent of methylation of the region as a whole. This method demonstrated efficacy for high-throughput screening, allowing for interrogation of numerous CpG sites in multiple tissues in a cost-efficient manner.
== Developments == There are many factors for drug developers to consider in developing new topical formulations. The first one is the effect of the drug vehicle. The medium to carry the topical drugs can affect the penetration of the drug active ingredient and efficacy. For example, this carrier can have a cooling, drying, emollient or protective action to suit the required conditions of the application site such as applying gel or lotion for hairy areas. Meanwhile, scientists need to match the type of preparation with the type of lesions. For example, they need to avoid oily ointments for acute weepy dermatitis. Chemists also need to consider the irritation or any sensitization potential to ensure that the topical application can be stable during storage and transport to maintain its efficacy. Another potential material is nanofiber-based dispersion to improve the adhesion of active ingredients on the skin. In order to enhance drug penetration into the skin, scientists have several ways to achieve their purposes by using chemical, biochemical, physical, and super saturation enhancement. Advanced Emulgel technology is a breakthrough in painkilling topical drugs. It helps the gel to enter deeply down the skin layer to strengthen the delivery of diclofenac to the point of pain so as to achieve better therapeutic effects by modifying the above properties.
Sources: en.wikipedia.org
== Origin and foundations == Dora Kunz, a theosophy promoter and one-time president (1975–1987) of the Theosophical Society in America, and Dolores Krieger, now Professor Emerita of Nursing Science, New York University, developed therapeutic touch in the 1970s. According to Krieger, therapeutic touch has roots in ancient healing practices, such as the laying on of hands, although it has no connection with religion or with faith healing. Krieger states that, "in the final analysis, it is the healee (client) who heals himself. The healer or therapist, in this view, acts as a human energy support system until the healee's own immunological system is robust enough to take over." Justification for TT has been sought in two fields: Martha E. Rogers' contemporal "Science of Unitary Human Beings", and quantum mechanics, in particular Fritjof Capra's mystical interpretation of the latter. A 2002 review found that neither justification was tenable: Rogers's theories were found to be inconsistent with the tenets of TT, while the overlap in terminology between the two could be ascribed to a lack of precision in Rogers's works, making them multi-interpretable. The quantum physics justification holds that the possibility to heal at a distance is made possible by a "global interconnectivity" of the universe, which TT adherents ascribe to an interpretation of Bell's theorem and the possibility of quantum nonlocality; this interpretation is not supported by experimental evidence.
Scientifically, sugar loosely refers to a number of compounds typically with the formula (CH2O)n. Some large classes of sugars, ranked in increasing order of molecular weight are monosaccharides, disaccharides, or oligosaccharides.
=== July === 1 July – Local Government Minister Lee Rowley formally writes to South Cambridgeshire District Council to request they end their trial of a four-day working week "immediately" amid concerns about "value for money". The scheme, launched in January 2023, is scheduled to run until March 2024. Seven Just Stop Oil protestors are arrested after attempting to disrupt the 2023 London Pride celebrations by blocking the route of the parade. Five people are subsequently charged in connection with the incident. 2 July – Amanda Pritchard, the Chief Executive of NHS England, announces the launch of a further seven specialist gambling addiction clinics in England as the number of people being referred for help because of gambling addiction sees a sharp increase. 3 July – Lord Chancellor and Justice Secretary Alex Chalk asks the Parole Board to reconsider its decision to release child killer Colin Pitchfork. Ranibizumab, a drug that can prevent blindness in premature babies, is made available on the NHS in England. 4 July – Thames Water is fined £3.3m for discharging millions of litres of untreated sewage into two rivers which resulted in the death of 1,400 fish. Forest Green Rovers appoint Hannah Dingley as their caretaker manager, making her the first woman to manage a men's football team in English professional football. 5 July – Train companies in England launch a 21-day consultation over plans to closing hundreds of ticket offices. Two Just Stop Oil protestors briefly halt play at the 2023 Wimbledon Championships by invading the tennis court and throwing orange confetti.
In April 1921, using the "well-equipped, funded laboratory" of John Macleod at the Physiology Department of the University of Toronto, Frederick Banting and Charles Best began investigating processes through which "the active principle of the extracts of degenerated [bovine] pancreas" could potentially be preserved without being destroyed (as was the case with the (then) current extraction processes).
In children, orthodontic treatment to expand the volume of the nasal airway, such as nonsurgical rapid palatal expansion, is common. Since the palatal suture is fused in adults, regular RPE using tooth-borne expanders cannot be performed. Mini-implant-assisted rapid palatal expansion (MARPE) has been recently developed as a non-surgical option for the transverse expansion of the maxilla in adults. This method increases the volume of the nasal cavity and nasopharynx, leading to increased airflow and reduced respiratory arousals during sleep. Changes are permanent with minimal complications.
Sources: en.wikipedia.org
The DNA pass through a gauge needle several times to physically tear the DNA into fine pieces. French pressure cells pass DNA through a narrow valve under high pressure to create high shearing forces. With a French press, the shear force can be carefully modulated by adjusting the piston pressure. The Press provides a single pass through the point of maximum shear force, limiting damage to delicate biological structures due to repeated shear, as occurs in other disruption methods. In transposome mediated fragmentation (tagmentation) transposomes are prepared with DNA that is afterwards cut so that the transposition events result in fragmented DNA with adapters (instead of an insertion). The relative concentration of transposomes and DNA must be appropriate.
An interview with Francis Crick and Christof Koch, 2001 Archived 3 March 2009 at the Wayback Machine Listen to Francis Crick The Quest for Consciousness Archived 3 March 2009 at the Wayback Machine – The Quest for Consciousness – 65 minute audio program — a conversation on Consciousness with neurobiologist Francis Crick of the Salk Institute and neurobiologist Christof Koch from Caltech. Listen to Francis Crick and James Watson talking on the BBC in 1962, 1972, and 1974. The Impact of Linus Pauling on Molecular Biology – a 1995 talk delivered by Crick at Oregon State University About his work
== Research == The first-in-human study, a phase 1 trial, was initiated in October 2017 and completed in September 2020 in postmenopausal women with breast cancer. The study investigated oral doses of vosilasarm of 50 mg/day to 150 mg/day, with the maximum tolerated dose found to be 100 mg/day. A phase 1/2 study proposal of vosilasarm for treatment of breast cancer was published in 2023. It will recruit up to 128 patients.
Xenon-135 is a radioactive isotope of xenon, produced as a fission product of uranium. It has a half-life of 9.14 hours and is the most powerful known neutron-absorbing nuclear poison (having a neutron absorption cross-section of about 2 million barns). The overall yield of xenon-135 from fission is 6.3%, without considering any loss by neutron capture. 135Xe exerts a significant effect on nuclear reactor operation (xenon pit). It is discharged to the atmosphere in small quantities by some nuclear power plants.
Sources: en.wikipedia.org
Water promotes hydrolysis and deamidation, so removing it slows degradation during transport and storage. The dry solid is also less prone to microbial growth than a solution. Reconstitution is therefore performed close to the point of use.
Reversed-phase high-performance liquid chromatography is the standard method for purity and related substances. It separates the main peak from deletion sequences and oxidation products. Mass spectrometry is frequently used alongside it to confirm molecular identity.
Aggregates, truncated sequences, and oxidation products receive the most attention. Size-exclusion chromatography covers aggregates, while reversed-phase methods resolve many chemical variants. Limits are set according to the route of administration and the expected exposure.
It is a dual GIP and GLP-1 receptor agonist, frequently grouped with incretin-based peptide therapeutics. It is a peptide rather than a small molecule and is given by subcutaneous injection.